• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用2A肽通过多亚基疱疹病毒糖蛋白复合物引发强效中和抗体。

Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.

作者信息

Wussow Felix, Chiuppesi Flavia, Meng Zhuo, Martinez Joy, Nguyen Jenny, Barry Peter A, Diamond Don J

机构信息

Department of Experimental Therapeutics, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Department of Experimental Therapeutics, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

出版信息

J Virol Methods. 2018 Jan;251:30-37. doi: 10.1016/j.jviromet.2017.10.006. Epub 2017 Oct 6.

DOI:10.1016/j.jviromet.2017.10.006
PMID:28989096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682205/
Abstract

Neutralizing antibodies (NAb) interfering with glycoprotein complex-mediated virus entry into host cells are thought to contribute to the protection against herpesvirus infection. However, using herpesvirus glycoprotein complexes as vaccine antigens can be complicated by the necessity of expressing multiple subunits simultaneously to allow efficient complex assembly and formation of conformational NAb epitopes. By using a novel bacterial artificial chromosome (BAC) clone of the clinically deployable Modified Vaccinia Ankara (MVA) vector and exploiting ribosomal skipping mediated by 2A peptides, MVA vectors were generated that expressed self-processing subunits of the human cytomegalovirus (HCMV) pentamer complex (PC) composed of gH, gL, UL128, UL130, and UL131A. These MVA vectors expressed 2A-linked HCMV PC subunits that were efficiently cleaved and transported to the cell surface as protein complexes forming conformational neutralizing epitopes. In addition, vaccination of mice by only two immunizations with these MVA vectors resulted in potent HCMV NAb responses that remained stable over a period of at least six months. This method of eliciting NAb by 2A-linked, self-processing HCMV PC subunits could contribute to develop a HCMV vaccine candidate and may serve as a template to facilitate the development of subunit vaccine strategies against other herpesviruses.

摘要

人们认为,干扰糖蛋白复合体介导的病毒进入宿主细胞的中和抗体(NAb)有助于预防疱疹病毒感染。然而,将疱疹病毒糖蛋白复合体用作疫苗抗原可能会很复杂,因为需要同时表达多个亚基,以实现有效的复合体组装和构象性NAb表位的形成。通过使用临床可用的改良痘苗病毒安卡拉(MVA)载体的新型细菌人工染色体(BAC)克隆,并利用由2A肽介导的核糖体跳跃,构建了表达人巨细胞病毒(HCMV)五聚体复合体(PC)自我加工亚基的MVA载体,该复合体由gH、gL、UL128、UL130和UL131A组成。这些MVA载体表达2A连接的HCMV PC亚基,这些亚基被有效切割并作为形成构象性中和表位的蛋白复合体转运到细胞表面。此外,用这些MVA载体仅对小鼠进行两次免疫接种就产生了强效的HCMV NAb反应,且在至少六个月的时间内保持稳定。这种通过2A连接的、自我加工的HCMV PC亚基引发NAb的方法可能有助于开发一种HCMV候选疫苗,并可作为促进针对其他疱疹病毒的亚单位疫苗策略开发的模板。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/9231aee57871/nihms912560f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/88fba136826a/nihms912560f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/eaedc13be495/nihms912560f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/edba0c60702d/nihms912560f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/9231aee57871/nihms912560f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/88fba136826a/nihms912560f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/eaedc13be495/nihms912560f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/edba0c60702d/nihms912560f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c857/5682205/9231aee57871/nihms912560f4.jpg

相似文献

1
Exploiting 2A peptides to elicit potent neutralizing antibodies by a multi-subunit herpesvirus glycoprotein complex.利用2A肽通过多亚基疱疹病毒糖蛋白复合物引发强效中和抗体。
J Virol Methods. 2018 Jan;251:30-37. doi: 10.1016/j.jviromet.2017.10.006. Epub 2017 Oct 6.
2
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.基于包膜糖蛋白gH/gL五聚体复合物的人巨细胞病毒疫苗。
PLoS Pathog. 2014 Nov 20;10(11):e1004524. doi: 10.1371/journal.ppat.1004524. eCollection 2014 Nov.
3
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.多抗原修饰的安卡拉痘苗病毒疫苗载体在小鼠体内诱导针对人巨细胞病毒的体液和细胞免疫应答。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01012-18. Print 2018 Oct 1.
4
A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.基于恒河猴巨细胞病毒 UL128 复合物的疫苗可诱导恒河猴产生广泛中和抗体。
J Virol. 2013 Feb;87(3):1322-32. doi: 10.1128/JVI.01669-12. Epub 2012 Nov 14.
5
Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.针对人巨细胞病毒gH/gL五聚体的疫苗衍生中和抗体可有效阻断原代细胞滋养层感染。
J Virol. 2015 Dec;89(23):11884-98. doi: 10.1128/JVI.01701-15. Epub 2015 Sep 16.
6
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.使用安卡拉痘苗病毒和可溶性蛋白通过人巨细胞病毒五聚体复合物在小鼠中诱导中和抗体的同源和异源初免-加强疫苗方法的比较。
PLoS One. 2017 Aug 16;12(8):e0183377. doi: 10.1371/journal.pone.0183377. eCollection 2017.
7
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies.载体共递送人巨细胞病毒 gH 和 gL 蛋白可引发有效的补体非依赖中和抗体。
Vaccine. 2013 Jan 30;31(6):919-26. doi: 10.1016/j.vaccine.2012.12.009. Epub 2012 Dec 14.
8
Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system.用于疫苗的人巨细胞病毒五聚体复合物在CHO系统中的表达。
Biotechnol Bioeng. 2015 Dec;112(12):2505-15. doi: 10.1002/bit.25670. Epub 2015 Jul 31.
9
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.表达三种免疫显性巨细胞病毒抗原的减毒痘病毒作为巨细胞病毒感染的疫苗策略。
J Clin Virol. 2006 Mar;35(3):324-31. doi: 10.1016/j.jcv.2005.09.018. Epub 2006 Jan 4.
10
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.人巨细胞病毒gH/gL/UL128/UL130/UL131A复合物在小鼠体内引发高效中和抗体。
Vaccine. 2014 Jun 24;32(30):3796-804. doi: 10.1016/j.vaccine.2014.05.004. Epub 2014 May 14.

引用本文的文献

1
Systematic identification and characterization of eukaryotic and viral 2A peptide-bond-skipping sequences.真核生物和病毒2A肽键跳跃序列的系统鉴定与表征
Cell Rep. 2025 Jul 22;44(7):115822. doi: 10.1016/j.celrep.2025.115822. Epub 2025 Jun 18.
2
A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry.一种针对改良安卡拉痘苗病毒(MVA)包膜蛋白的新型单克隆抗体,可用于流式细胞术测定 MVA 病毒滴度。
Viruses. 2024 Oct 17;16(10):1628. doi: 10.3390/v16101628.
3
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice.

本文引用的文献

1
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.使用安卡拉痘苗病毒和可溶性蛋白通过人巨细胞病毒五聚体复合物在小鼠中诱导中和抗体的同源和异源初免-加强疫苗方法的比较。
PLoS One. 2017 Aug 16;12(8):e0183377. doi: 10.1371/journal.pone.0183377. eCollection 2017.
2
Structural basis for potent antibody-mediated neutralization of human cytomegalovirus.强效抗体介导的人巨细胞病毒中和作用的结构基础
Sci Immunol. 2017 Jun 30;2(12). doi: 10.1126/sciimmunol.aan1457.
3
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.
多价 MVA 载体疫苗在恒河猴中诱导 EBV 中和抗体,减少人源化小鼠中的 EBV 感染。
Front Immunol. 2024 Sep 13;15:1445209. doi: 10.3389/fimmu.2024.1445209. eCollection 2024.
4
Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection or .卡波西肉瘤相关疱疹病毒补体控制蛋白(KCP)和糖蛋白K8.1对于病毒感染并非必需的,或者…… (原文此处不完整)
J Virol. 2024 Jun 13;98(6):e0057624. doi: 10.1128/jvi.00576-24. Epub 2024 May 20.
5
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.使用合成痘病毒平台开发多抗原性SARS-CoV-2疫苗。
Res Sq. 2020 Jul 17:rs.3.rs-40198. doi: 10.21203/rs.3.rs-40198/v1.
6
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine.基于合成痘病毒的新型冠状病毒 2 型疫苗的研发
bioRxiv. 2020 Jul 2:2020.07.01.183236. doi: 10.1101/2020.07.01.183236.
7
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission.MVA载体五聚体复合物(PC)疫苗和gB疫苗可改善豚鼠巨细胞病毒攻击后的妊娠结局,但只有gB疫苗可减少垂直传播。
Vaccines (Basel). 2019 Nov 14;7(4):182. doi: 10.3390/vaccines7040182.
8
HCMV Envelope Glycoprotein Diversity Demystified.巨细胞病毒包膜糖蛋白多样性揭秘。
Front Microbiol. 2019 May 15;10:1005. doi: 10.3389/fmicb.2019.01005. eCollection 2019.
9
A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.五十载探索:移植和先天性感染中巨细胞病毒疫苗的前景。
Expert Rev Vaccines. 2018 Oct;17(10):889-911. doi: 10.1080/14760584.2018.1526085. Epub 2018 Oct 3.
10
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.多抗原修饰的安卡拉痘苗病毒疫苗载体在小鼠体内诱导针对人巨细胞病毒的体液和细胞免疫应答。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01012-18. Print 2018 Oct 1.
预先存在的抗体可预防猴子的先天性巨细胞病毒感染。
JCI Insight. 2017 Jul 6;2(13). doi: 10.1172/jci.insight.94002.
4
The COMPLEXity in herpesvirus entry.疱疹病毒进入过程中的复杂性。
Curr Opin Virol. 2017 Jun;24:97-104. doi: 10.1016/j.coviro.2017.04.006. Epub 2017 May 21.
5
Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.人巨细胞病毒UL128内连续中和表位的鉴定
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01857-16. Print 2017 Mar 15.
6
Cytomegalovirus vaccines under clinical development.正在临床开发中的巨细胞病毒疫苗。
J Virus Erad. 2016 Oct 5;2(4):198-207. doi: 10.1016/S2055-6640(20)30872-4.
7
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.血小板衍生生长因子-α 受体是人类巨细胞病毒 gHgLgO 三聚体的细胞受体。
Nat Microbiol. 2016 Jun 6;1(8):16082. doi: 10.1038/nmicrobiol.2016.82.
8
Status of vaccine research and development of vaccines for herpes simplex virus.单纯疱疹病毒疫苗的研发现状
Vaccine. 2016 Jun 3;34(26):2948-2952. doi: 10.1016/j.vaccine.2015.12.076. Epub 2016 Mar 11.
9
gH/gL supercomplexes at early stages of herpesvirus entry.疱疹病毒进入早期阶段的gH/gL超复合体
Curr Opin Virol. 2016 Jun;18:1-8. doi: 10.1016/j.coviro.2016.01.010. Epub 2016 Feb 2.
10
Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.人巨细胞病毒gH/gL/gO和五聚体细胞进入复合体的抗原特性揭示了强效中和人抗体的结合位点。
PLoS Pathog. 2015 Oct 20;11(10):e1005230. doi: 10.1371/journal.ppat.1005230. eCollection 2015 Oct.